| Trial ID: | L0590 |
| Source ID: | NCT03150667
|
| Associated Drug: |
Ticagrelor
|
| Title: |
Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD
|
| Acronym: |
CPRS-CKD
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Diseases|Acute Coronary Syndrome
|
| Interventions: |
DRUG: Ticagrelor|DRUG: Clopidogrel
|
| Outcome Measures: |
Primary: Occurrence of all-cause mortality, non-fatal myocardial infarction (MI), or ischemic stroke, Occurrence of all-cause mortality, non-fatal myocardial infarction (MI), or ischemic stroke, 1 year from date of admission | Secondary: Occurrence of bleeding, Incidence of BARC \>3 bleeding over a period of 1-year from hospital admission, 1 year from date of admission|Need for ischemia driven urgent coronary revascularization, Need for ischemia driven urgent coronary revascularization (UCR) over a period of 1-year from hospital admission, 1 year from date of admission|Occurrence of MACE events, Comparison of 12-month post-randomization MACE events, a composite of all-cause death, MI, ischemic stroke, or UCR in participant groups, 1 year from date of admission|Length of hospital stay and readmission, Post-PCI length of hospital stay and readmission ≤ 1 year of initial discharge, 1 year from date of admission
|
| Sponsor/Collaborators: |
Sponsor: North Texas Veterans Healthcare System
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
220
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2017-04-10
|
| Completion Date: |
2020-04-30
|
| Results First Posted: |
|
| Last Update Posted: |
2018-05-25
|
| Locations: |
Durham VA Medical Center, Durham, North Carolina, 27705, United States|VA North Texas Health Care System, Dallas, Texas, 75216, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT03150667
|
